all report title image

STROKE DIAGNOSTICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Stroke Diagnostics Market, By Stroke Type (Ischemic Stroke, Hemorrhagic Stroke, and Transient Ischemic Attack), By Imaging Test Type (Computerized Tomography (CT) Scan, Magnetic Resonance Imaging (MRI), Carotid Ultrasound, Echocardiogram, Positron Emission Tomography (PET), and Others, By End User (Diagnostic Laboratories, Hospitals, Specialty Clinics, Academic & Research Institutes, and Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

  • Published In : Mar 2024
  • Code : CMI6794
  • Pages :167
  • Formats :
      Excel and PDF
  • Industry : Medical Devices

Key Developments

  • In December 2023, Siemens Healthineers, a medical device company, and S.I.S Hospital, a major private healthcare hospital in Vietnam, unveiled the cutting-edge NAEOTOM Alpha, a huge step forward in diagnostic imaging. In a parallel development, S.I.S Hospital and Siemens Healthineers inked a master agreement for research partnership, with the goal of accelerating acute stroke protocols utilizing the most recent Deep Resolve method on MRI systems.
  • In October 2023, Brainomix Ltd, an Artificial Intelligence (AI)-powered medtech solutions company, and Nanoflex Robotics AG, a remote robotic surgical company based in Switzerland, received a grant under the "UK - Switzerland Bilateral: Collaborative R&D" program. The companies will collaborate to develop an integrated remote diagnosis and treatment platform for stroke powered by artificial intelligence.
  • In July 2023, Hyperfine, Inc., the company behind the first U.S. Food and Drug Administration -cleared point-of-care magnetic resonance imaging (MRI) equipment, Swoop, announced the start of an international, multi-site observational research called ACTION PMR (ACuTe Ischemic StrOke DetectioN with Portable MR). Hyperfine Inc. has established an advisory group of world-renowned stroke experts to help with its acute stroke care activities.
  • In July 2022, Viz.ai, the premier AI-powered disease detection and intelligent care coordination platform, announced a partnership with Hyperfine, Inc. Viz.ai's core product, Viz LVO, which uses powerful deep learning to send time-sensitive information about stroke victims directly to a professional who can intervene and treat.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.